Market Intelligence Ecosystem
Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Executive Director Sunil
Indoco Remedies Limited (NSE: INDOCO) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Aditi Panandikar -- Managing Director Sundeep V. Bambolkar -- Joint Managing
IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi -- Executive Director and Chief Executive
FDC Ltd (NSE:FDC) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Varsharani Katre -- Company Secretary and Compliance Officer Sanjay Jain -- Chief Financial Officer Unidentified
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Utkarsh Gandhi -- General Manager - Investor Relations Brendan
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Raj Kumar Baheti -- Director - Finance and Chief Financial
Indoco Remedies Limited (NSE:INDOCO) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Aditi Panandikar -- Managing Director Sundeep Bambolkar --
Hester Biosciences Limited (NSE:HESTERBIO) Q2 FY23 Earnings Concall dated Nov. 04, 2022 Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing Director
Eris Lifesciences Ltd (NSE:ERIS) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate Participants: Krishnakumar Vaidyanathan -- Executive Director and Chief Operating
Orchid Pharma Ltd (NSE:ORCHPHARMA) Q1 FY23 Earnings Concall dated Aug. 10, 2022 Corporate Participants: Mridul Dhanuka -- Executive Director Sunil Kumar Gupta --
SUVEN PHARMACEUTICALS LTD (NSE: SUVEN) Q1 FY23 Earnings Concall dated Aug. 08, 2022 Corporate Participants: Rishab Barar -- Investor Relations Venkat Jasti -- Managing Director Analysts:
On Friday, Torrent Pharma reported a 7.2 percent increase in its consolidated net profit to Rs 354 crore for the June 2022
Hikal Limited (NSE: HIKAL) Q4 FY22 Earnings Concall dated Jun. 03, 2022 Corporate Participants: Anish Swadi -- Senior President of Animal Health and Business
Alkem Laboratories Ltd. (NSE: ALKEM) Q4 FY22 Earnings Concall dated May. 13, 2022 Corporate Participants: Gagan Borana -- Investor Relations Sandeep Singh -- Managing Director Rajesh